Flputnam Investment Management Co. Has $6.80 Million Stock Position in Agilent Technologies, Inc. $A

Flputnam Investment Management Co. lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 11.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,960 shares of the medical research company’s stock after selling 6,669 shares during the period. Flputnam Investment Management Co.’s holdings in Agilent Technologies were worth $6,798,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in A. Board of the Pension Protection Fund acquired a new stake in Agilent Technologies in the fourth quarter valued at approximately $27,000. Navalign LLC acquired a new stake in Agilent Technologies in the fourth quarter valued at approximately $27,000. Physician Wealth Advisors Inc. boosted its position in Agilent Technologies by 490.0% in the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after buying an additional 196 shares in the last quarter. Entrust Financial LLC acquired a new stake in Agilent Technologies in the fourth quarter valued at approximately $31,000. Finally, Torren Management LLC acquired a new stake in Agilent Technologies in the fourth quarter valued at approximately $32,000.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent beat Q2 fiscal 2026 estimates, posting adjusted EPS of $1.49 versus the $1.40 consensus and revenue of $1.83 billion versus $1.80 billion expected, with revenue up 10% year over year. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its FY 2026 profit forecast, signaling confidence in demand for lab tools and equipment used in research and diagnostics. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Agilent’s FY 2026 guidance came in slightly above consensus, while its Q3 revenue outlook matched expectations and EPS guidance was near the top of the range, reinforcing stable near-term execution. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: Analysts turned more constructive, with RBC initiating/covering the stock at outperform and Baird lifting its price target, suggesting more upside if the company keeps delivering. Benzinga analyst update
• Neutral Sentiment: Agilent’s latest results also showed GAAP EPS of $1.20 and highlighted solid profitability metrics, but these were secondary to the stronger non-GAAP performance and guidance update.

Analyst Ratings Changes

A number of analysts have weighed in on A shares. Robert W. Baird raised their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday. Royal Bank Of Canada started coverage on shares of Agilent Technologies in a research report on Wednesday. They issued an “outperform” rating and a $153.00 target price on the stock. UBS Group cut their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. TD Cowen cut their target price on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, Wells Fargo & Company cut their target price on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $162.40.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $115.82 on Thursday. The firm has a market cap of $32.73 billion, a PE ratio of 25.57, a price-to-earnings-growth ratio of 2.42 and a beta of 1.22. The firm’s fifty day moving average is $114.99 and its 200-day moving average is $128.79. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The company had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. Agilent Technologies’s revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s payout ratio is 22.52%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.